---
title: Heart Transplantation in High-Risk Recipients Employing Donor Marginal Grafts
  Preserved With <em>Ex-Vivo</em> Perfusion
date: '2023-08-07'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37547752/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20230807180848&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: Extending selection criteria to face donor organ shortage in heart transplantation
  (HTx) may increase the risk of mortality. Ex-vivo normothermic perfusion (EVP) limits
  ischemic time allowing assessment of graft function. We investigated the outcome
  of HTx in 80 high-risk recipients transplanted with marginal donor and EVP-preserved
  grafts, from 2016 to 2021. The recipients median age was 57 years (range, 13-75),
  with chronic renal failure in 61%, impaired liver function in 11% and ...
disable_comments: true
---
Extending selection criteria to face donor organ shortage in heart transplantation (HTx) may increase the risk of mortality. Ex-vivo normothermic perfusion (EVP) limits ischemic time allowing assessment of graft function. We investigated the outcome of HTx in 80 high-risk recipients transplanted with marginal donor and EVP-preserved grafts, from 2016 to 2021. The recipients median age was 57 years (range, 13-75), with chronic renal failure in 61%, impaired liver function in 11% and ...